A Critical Proton MR Spectroscopy Marker of Alzheimer’s Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ 4 Mexico City Children and Their Parents
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Severe air pollution exposures produce systemic, respiratory, myocardial, and brain inflammation and Alzheimer’s disease (AD) hallmarks in clinically healthy children. We tested whether hippocampal metabolite ratios are associated with contrasting levels of air pollution, APOE, and body mass index (BMI) in paired healthy children and one parent sharing the same APOE alleles. We used 1 H-MRS to interrogate bilateral hippocampal single-voxel in 57 children (12.45 ± 3.4 years) and their 48 parents (37.5 ± 6.78 years) from a low pollution city versus Mexico City (MC). NAA/Cr, Cho/Cr, and mI/Cr metabolite ratios were analyzed. The right hippocampus NAA/Cr ratio was significantly different between cohorts ( p = 0.007). The NAA/Cr ratio in right hippocampus in controls versus APOE ɛ 4 MC children and in left hippocampus in MC APOE ɛ 4 parents versus their children was significantly different after adjusting for age, gender, and BMI ( p = 0.027 and 0.01, respectively). The NAA/Cr ratio is considered reflective of neuronal density/functional integrity/loss of synapses/higher pTau burden, thus a significant decrease in hippocampal NAA/Cr ratios may constitute a spectral marker of early neurodegeneration in young urbanites. Decreases in NAA/Cr correlate well with cognitive function, behavioral symptoms, and dementia severity; thus, since the progression of AD starts decades before clinical diagnosis, our findings support the hypothesis that under chronic exposures to fine particulate matter and ozone above the standards, neurodegenerative processes start in childhood and APOE ɛ 4 carriers are at higher risk. Gene and environmental factors are critical in the development of AD and the identification and neuroprotection of young urbanites at high risk must become a public health priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
The pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812 · cited 1×
“Equally important, children in Mexico City have significant correlations between MRS altered metabolic ratios in key anatomical regions and targeted WISC-R subtests, all in keeping with involvement of AD target areas [46, 48, 50-55].”
ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
Kanekiyo, T., Xu, H., & Bu, G. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.045 · Cited by 608
Jung, C.-R., Lin, Y.-T., & Hwang, B.-F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-140855 · Cited by 380 · cited 1×
“AD and Parkinson’s disease [7, 8, 11, 15, 16]. association between the risk of AD [26] and smaller total cerebral brain volume in older adults [27] with exposure to elevated levels of PM 2 .”
APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
Michaelson, D. M. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.015 · Cited by 331
Dean, D. C., Jerskey, B. A., Chen, K., Protas, H., Thiyyagura, P., Roontiva, A., O'Muircheartaigh, J., Dirks, H., Waskiewicz, N., Lehman, K., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4544 · Cited by 263
Wolk, D. A., Dickerson, B. C., Initiative, T. A. D. N., Weiner, M., Aiello, M., Aisen, P., Albert, M. S., Alexander, G., Anderson, H. S., Anderson, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001412107 · Cited by 248
Characterizing longitudinal white matter development during early childhood
Dean, D. C., O’Muircheartaigh, J., Dirks, H., Waskiewicz, N., Walker, L., Doernberg, E., Piryatinsky, I., & Deoni, S. C. L. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0763-3 · Cited by 174
Newman, N. C., Ryan, P., LeMasters, G., Levin, L., Bernstein, D., Hershey, G. K. K., Lockey, J. E., Villareal, M., Reponen, T., Grinshpun, S., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205555 · Cited by 160 · cited 1×
“There is significant concern about the effects of air pollutants upon the developing brain [1-16].”
Calderón-Garcidueñas, L., Mora-Tiscareño, A., Franco-Lira, M., Cross, J. V., Engle, R., Aragón-Flores, M., Gómez-Garza, G., Jewells, V., Medina-Cortina, H., Solorio, E., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00104 · Cited by 36
Self-citation
Cited by
Clinical effects of air pollution on the central nervous system; a review
Babadjouni, R. M., Hodis, D. M., Radwanski, R., Durazo, R., Patel, A., Liu, Q., & Mack, W. J. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.04.028 · Cited by 177
Matura, S., Fleckenstein, J., Deichmann, R., Engeroff, T., Füzéki, E., Hattingen, E., Hellweg, R., Lienerth, B., Pilatus, U., Schwarz, S., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.135 · Cited by 97
Croze, M. L., & Zimmer, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170857 · Cited by 78
Metadata
- Authors
- Calderón-Garcidueñas, L., Mora-Tiscareño, A., Melo-Sánchez, G., Rodríguez-Díaz, J., Torres-Jardón, R., Styner, M., Mukherjee, P. S., Lin, W., & Jewells, V.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2015-10-27
- Volume
- 48
- Issue
- 4
- Pages
- 1065-1075
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1845752401
- Cited by
- 46
- References
- 10
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Critical Proton MR Spectroscopy Marker of Alzheimer’s Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ 4 Mexico City Children and Their Parents. https://app.cochat.ai/papers/10.3233/jad-150415
- The paper
- Calderón-Garcidueñas, L., Mora-Tiscareño, A., Melo-Sánchez, G., Rodríguez-Díaz, J., Torres-Jardón, R., Styner, M., Mukherjee, P. S., Lin, W., & Jewells, V. (2015). A Critical Proton MR Spectroscopy Marker of Alzheimer’s Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ 4 Mexico City Children and Their Parents. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-150415
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.